Showing results (421-430 of 592) with videos related to

Sort By:
Pageof 60
Annals of the Rheumatic Diseases|April 1, 1992
Antibodies to protein P in systemic lupus erythematosusL S Teh, A E Bedwell, D A Isenberg, et al.
QJM : Monthly Journal of the Association of Physicians|February 22, 2008
A pilot study of combination anti-cytokine and anti-lymphocyte biological therapy in rheumatoid arthritisA W Morgan, G Hale, P R U B Rebello, et al.
Annals of the Rheumatic Diseases|June 18, 2003
Overexpression of transcripts containing LINE-1 in the synovia of patients with rheumatoid arthritisM Ali, D J Veale, R J Reece, et al.
QJM : Monthly Journal of the Association of Physicians|June 1, 1997
Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitisD Adu, A Pall, R A Luqmani, et al.
Annals of the Rheumatic Diseases|January 17, 2014
Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trialJ S Smolen, P Emery, G F Ferraccioli, et al.
Annals of the Rheumatic Diseases|April 15, 2005
Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging studyH Marzo-Ortega, D McGonagle, S Jarrett, et al.
Microorganisms|June 27, 2024
Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study in Three Communities in the United States and LebanonMohamad Yasmin, Mohamad Ali Tfaily, Rayyan Wazzi Mkahal, et al.
Clinical Therapeutics|October 9, 2022
Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer DiseaseMalaz Boustani, Erin G Doty, Louis P Garrison, et al.
Annals of the Rheumatic Diseases|February 9, 2008
The optimal assessment of the rheumatoid arthritis hindfoot: a comparative study of clinical examination, ultrasound and high field MRIR J Wakefield, J E Freeston, P O'Connor, et al.
Alimentary Pharmacology & Therapeutics|March 2, 2017
Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritisP B Allen, P Olivera, P Emery, et al.
Pageof 60